Equities

Hofseth Biocare ASA

Hofseth Biocare ASA

Actions
  • Price (EUR)0.085
  • Today's Change-0.002 / -2.52%
  • Shares traded0.00
  • 1 Year change-53.42%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of NOK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments213047
Total Receivables, Net151410
Total Inventory8311791
Prepaid expenses------
Other current assets, total131522
Total current assets131176170
Property, plant & equipment, net166169186
Goodwill, net------
Intangibles, net556153
Long term investments385.906.78
Note receivable - long term------
Other long term assets0.000.00--
Total assets390411416
LIABILITIES
Accounts payable55146124
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases401315
Other current liabilities, total1571312
Total current liabilities252172151
Total long term debt9790123
Total debt137103138
Deferred income tax------
Minority interest(0.69)(0.69)(0.69)
Other liabilities, total--0.811.35
Total liabilities348262275
SHAREHOLDERS EQUITY
Common stock3.953.953.58
Additional paid-in capital38145137
Retained earnings (accumulated deficit)000
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--00
Total equity42149141
Total liabilities & shareholders' equity390411416
Total common shares outstanding395395358
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.